However, they further found that this was only marginally significant when they restricted their examination to only PanNET patients [ 15 ].
← all excerpts
Loss of Progesterone Receptor Expression Is an Early Tumorigenesis Event Associated with Tumor Progression and Shorter Survival in Pancreatic Neuroendocrine Tumor Patients.
1
—
—